Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.22
Delayed Data
As of 12:20pm ET
 -0.26 / -7.47%
Today’s Change
1.65
Today|||52-Week Range
19.80
+85.06%
Year-to-Date

Today’s Trading

Previous close3.48
Today’s open3.48
Day’s range3.19 - 3.49
Volume198,842
Average volume (3 months)415,006
Market cap$50.8M
Dividend yield--
Data as of 12:20pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-62.50%
Earnings growth (this year)-31.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-55.95%
P/E ratioNM
Price/Sales9.22
Price/Book1.52

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc+0.80+4.21%
CAPRCapricor Therapeutic...-0.07-2.97%
GLMDGalmed Pharmaceutica...-0.03-0.72%
APDNApplied DNA Sciences...0.000.00%
Data as of 11:51am ET, 01/19/2017

Financials

Next reporting dateMarch 15, 2017
EPS forecast (this quarter)-$1.58
Annual revenue (last year)$24.5M
Annual profit (last year)-$68.7M
Net profit margin-280.83%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
Chief Operating Officer &
Executive Vice President
Thomas R. Cannell
Corporate headquarters
La Jolla, California

Forecasts


Search for Jobs